Icariin was found to regulate the Wnt/β-catenin and RANKL/RANK/OPG signaling pathways, promoting osteogenesis, increasing bone mineral density and serum estrogen levels in ovariectomized rats, while significantly reducing bone resorption and osteoporosis risk. This evidence concerns the gene TNFSF11 and osteoporosis.